The Trump administration plans to send U.S. citizens exposed to Ebola to Kenya for observation and treatment, three people with knowledge of the plans told The New York Times. Here’s the latest on the ...

Hershey, Pa.-based Penn State Health reported an operating income of $77.6 million (2.1% margin) through the first three quarters of 2026, up from $60.4 million (1.8% operating margin) during the same ...

Hospitalists become 1st Providence physicians in Washington to unionize, joining Northwest Medicine United across five Seattle-area campuses.

Epic is continuing to grow its hospital EHR market share lead, though its gains weren’t as pronounced in 2025 as in previous years. Here are 14 things to know about the EHR giant’s run of success: 1.

Amazon is making a leadership change at its healthcare division, with Neil Lindsay, senior vice president of Amazon Health Services, stepping down after more than 15 years at the company. Mr. Lindsay ...

Hartford (Conn.) HealthCare patients are among approximately 22,500 individuals whose information was accessed after an unauthorized third party gained entry to payment accounts on Connecticut’s ...

Humana’s CenterWell Pharmacy has initiated full operations at its CenterWell Pharmacy mail-order distribution center in Orlando, Fla. The $83 ...

UNMC named discrimination retaliation lawsuit filed by Dr. Sunil Hingorani alleges racial bias and retaliation at Nebraska Medicine.

Penn Medicine deploy clinical AI agents to reduce wait times and support clinicians across urgent, primary and specialty care settings.

The Food and Drug Administration granted de novo approval to Modius Spero, marking it the world’s first neuromodulation device authorized to ...

GoodRx has launched GoodRx Companion, a $14.99 monthly subscription program focused on lowering out-of-pocket healthcare costs. The membership ...

Researchers from the University of Houston and University of Michigan in Ann Arbor have developed a dual-target drug designed to overcome immunotherapy resistance in pancreatic cancer. The research ...